Goldman Sachs
GDRX icon

Goldman Sachs’s GoodRx Holdings GDRX Stock Holding History

Goldman Sachs’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
858,326
-199,635
-19% -$507K ﹤0.01% 4510
2026
Q1 		$2.07M Sell
1,057,961
-521,313
-33% -$1.22M ﹤0.01% 4516
2025
Q4 		$4.28M Buy
1,579,274
+305,593
+24% +$1M ﹤0.01% 3889
2025
Q3 		$5.39M Buy
1,273,681
+983,641
+339% +$4.32M ﹤0.01% 3565
2025
Q2 		$1.44M Sell
290,040
-493,338
-63% -$2.14M ﹤0.01% 4428
2025
Q1 		$3.45M Buy
783,378
+54,783
+8% +$257K ﹤0.01% 3705
2024
Q4 		$3.39M Buy
728,595
+620,479
+574% +$3.41M ﹤0.01% 3829
2024
Q3 		$750K Buy
108,116
+67,530
+166% +$530K ﹤0.01% 4827
2024
Q2 		$317K Sell
40,586
-1,334
-3% -$9.88K ﹤0.01% 5076
2024
Q1 		$298K Sell
41,920
-13,272
-24% -$87.8K ﹤0.01% 4977
2023
Q4 		$370K Sell
55,192
-119,174
-68% -$671K ﹤0.01% 4897
2023
Q3 		$982K Sell
174,366
-29,708
-15% -$198K ﹤0.01% 4283
2023
Q2 		$1.13M Sell
204,074
-1,111,466
-84% -$5.98M ﹤0.01% 4269
2023
Q1 		$8.22M Buy
1,315,540
+644,205
+96% +$3.59M ﹤0.01% 2609
2022
Q4 		$3.13M Sell
671,335
-213,348
-24% -$1.05M ﹤0.01% 3578
2022
Q3 		$4.13M Buy
884,683
+358,562
+68% +$2.26M ﹤0.01% 3304
2022
Q2 		$3.12M Buy
526,121
+451,405
+604% +$5.02M ﹤0.01% 3636
2022
Q1 		$1.44M Sell
74,716
-1,864,355
-96% -$42.8M ﹤0.01% 4530
2021
Q4 		$63.4M Buy
1,939,071
+714,306
+58% +$28.7M 0.01% 1145
2021
Q3 		$50.2M Sell
1,224,765
-1,590,054
-56% -$57.7M 0.01% 1283
2021
Q2 		$101M Buy
2,814,819
+1,139,666
+68% +$42.1M 0.02% 724
2021
Q1 		$65.4M Sell
1,675,153
-636,279
-28% -$28.6M 0.02% 949
2020
Q4 		$93.2M Buy
2,311,432
+2,257,237
+4,165% +$104M 0.02% 668
2020
Q3 		$3.01M Buy
+54,195
New +$2.87M ﹤0.01% 3279

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs's GDRX Position: Q2 2026 in Review

Goldman Sachs reduced its GoodRx Holdings (GDRX) stake by 19% in Q2 2026, selling an estimated $507K and leaving 858,326 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #4510.

Goldman Sachs first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $101M in Q2 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Goldman Sachs held 858,326 shares of GoodRx Holdings worth $2.47M as of Q2 2026.
  • Goldman Sachs sold 199,635 GoodRx Holdings shares in Q2 2026, an estimated $507K.
  • GoodRx Holdings made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4510 holding.
  • Goldman Sachs first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • Goldman Sachs's GoodRx Holdings position peaked at $101M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.